Skip to main content
SpringerLink
Log in

Prevalence and misdiagnosis of chronic heart failure in nursing home residents: the role of B-type natriuretic peptides

  • Original article
  • Published:
Netherlands Heart Journal Aims and scope Submit manuscript

Abstract

Background/objectives. Without knowing the exact CHF prevalence, chronic heart failure (CHF) occurs frequently in elderly people both inside and outside nursing homes. For a diagnosis we have to rely on physical examination and additional tests. We therefore run the risk of missing CHF diagnoses or of diagnosing CHF when we should not. Natriuretic peptide assays have emerged as a diagnostic test but their use in nursing home residents is limited. We examined the number of misdiagnoses, the CHF prevalence and the role of natriuretic peptide.

Method. Residents in one centre without aphasia, cognitive impairments or metastatic cancer were screened for CHF; the natriuretic peptide levels were measured separately.

Results. Of the 150 residents, 103 (64%) were included (79±11 years). The diagnosis of CHF was established in 24 of these 103 residents with NTproBNP 1871 (IQR 539 to 4262) and BNP 194 (IQR 92 to 460) pg/ml. A striking result was that of the 24 residents found to have CHF after the screening, 15 (66%) had previously been undetected: NT-proBNP 1146 (interquartile range (IQR) 228 to 3341) and BNP 200 (IQR 107 to 433) pg/ml. Moreover, in 13 out of 22 residents (62%) who had previously been thought to have CHF, the diagnosis was rejected: NT-proBNP 388 (IQR 174 to 719) and BPN 90 (IQR 35 to 128) pg/ml). Regarding the diagnostic accuracy of NT-proBNP and BNP, the optimal cut-off level of NT-proBNP was 450 pg/ml with a sensitivity of 0.71 and specificity of 0.67, and for BNP it was 100 pg/ml with a sensitivity of 0.71 and specificity of 0.70.

Conclusion. Both undetected and incorrect diagnoses of CHF were common. NT-proBNP and BNP were moderately accurate at diagnosing CHF. CHF prevalence was 23%. (Neth Heart J 2008;16: 123-8.)

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1

Similar content being viewed by others

References

  1. Cleland JG, Swedberg K, Follath F, Komajda M, Cohen-Solal A, Aguilar JC, et al. The EuroHeart Failure survey programme – a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J 2003;24:442-63.

    Google Scholar 

  2. Luchi RJ, Taffet GE, Teasdale TA. Congestive heart failure in the elderly. J Am Geriatr Soc 1991;39:810-25.

    Google Scholar 

  3. Januzzi JL Jr, Camargo CA, Anwaruddin S, Baggish AL, Chen AA, Krauser DG, et al. The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol 2005;95:948-54.

    Google Scholar 

  4. Morrison LK, Harrison A, Krishnaswamy P, Kazanegra R, Clopton P, Maisel A. Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea. J Am Coll Cardiol 2002;39:202-9.

    Google Scholar 

  5. Smith H, Pickering RM, Struthers A, Simpson I, Mant D. Biochemical diagnosis of ventricular dysfunction in elderly patients in general practice: observational study. BMJ 2000;320:906-8.

    Google Scholar 

  6. Tombaugh TN, McIntyre NJ. The mini-mental state examination: a comprehensive review. J Am Geriatr Soc 1992;40:922-35.

    Google Scholar 

  7. Krum H. The Task Force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure: full text (update 2005). Eur Heart J 2005;26:2472-4.

    Google Scholar 

  8. Shamsham F, Mitchell J. Essentials of the diagnosis of heart failure. Am Fam Physician 2000;61:1319-28.

    Google Scholar 

  9. Bruins S, Fokkema MR, Romer JW, Dejongste MJ, van der Dijs FP, van den Ouweland JM, et al. High intraindividual variation of B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with stable chronic heart failure. Clin Chem 2004;50:2052-8.

    Google Scholar 

  10. Quinones MA, Waggoner AD, Reduto LA, Nelson JG, Young JB, Winters WL Jr, et al. A new, simplified and accurate method for determining ejection fraction with two-dimensional echocardiography. Circulation 1981;64:744-53.

    Google Scholar 

  11. Mosterd A, Hoes AW, de Bruyne MC, Deckers JW, Linker DT, Hofman A, et al. Prevalence of heart failure and left ventricular dysfunction in the general population; The Rotterdam Study. Eur Heart J 1999;20:447-55.

    Google Scholar 

  12. Heckman GA, Misiaszek B, Merali F, Turpie ID, Patterson CJ, Flett N, et al. Management of heart failure in Canadian long-term care facilities. Can J Cardiol 2004;20:963-9.

    Google Scholar 

  13. Mair J. Monitoring of patients with heart failure. Scand J Clin Lab Invest Suppl 2005;240:99-106.

    Google Scholar 

  14. Rutten FH, Cramer MJ, Grobbee DE, Sachs AP, Kirkels JH, Lammers JW, et al. Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease. Eur Heart J 2005;26:1887-94.

    Google Scholar 

  15. Cowie MR, Jourdain P, Maisel A, Dahlstrom U, Follath F, Isnard R, et al. Clinical applications of B-type natriuretic peptide (BNP) testing. Eur Heart J 2003;24:1710-8.

    Google Scholar 

  16. Bando M, Ishii Y, Sugiyama Y, Kitamura S. Elevated plasma brain natriuretic peptide levels in chronic respiratory failure with cor pulmonale. Respir Med 1999;93:507-14.

    Google Scholar 

  17. Buckley MG, Sethi D, Markandu ND, Sagnella GA, Singer DR, MacGregor GA. Plasma concentrations and comparisons of brain natriuretic peptide and atrial natriuretic peptide in normal subjects, cardiac transplant recipients and patients with dialysis-independent or dialysis-dependent chronic renal failure. Clin Sci (Lond) 1992; 83:437-44.

    Google Scholar 

  18. Sayama H, Nakamura Y, Saito N, Kinoshita M. Why is the concentration of plasma brain natriuretic peptide in elderly inpatients greater than normal? Coron Artery Dis 1999;10:537-40.

    Google Scholar 

  19. Wallen T, Landahl S, Hedner T, Saito Y, Masuda I, Nakao K. Brain natriuretic peptide in an elderly population. J Intern Med 1997; 242:307-11.

    Google Scholar 

  20. Kohno M, Yokokawa K, Yasunari K, Kano H, Minami M, Hanehira T, et al. Changes in plasma cardiac natriuretic peptides concentrations during 1 year treatment with angiotensin-converting enzyme inhibitor in elderly hypertensive patients with left ventricular hypertrophy. Int J Clin Pharmacol Ther 1997;35:38-42.

    Google Scholar 

  21. Missouris CG, Grouzmann E, Buckley MG, Barron J, MacGregor GA, Singer DR. How does treatment influence endocrine mechanisms in acute severe heart failure? Effects on cardiac natriuretic peptides, the renin system, neuropeptide Y and catecholamines. Clin Sci (Lond) 1998;94:591-9.

    Google Scholar 

  22. Redfield MM, Rodeheffer RJ, Jacobsen SJ, Mahoney DW, Bailey KR, Burnett JC Jr. Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol 2002;40:976-82.

    Google Scholar 

  23. Mair J, Friedl W, Thomas S, Puschendorf B. Natriuretic peptides in assessment of left-ventricular dysfunction. Scand J Clin Lab Invest Suppl 1999;230:132-42.

    Google Scholar 

  24. Gambassi G, Lapane K, Sgadari A, Landi F, Carbonin P, Hume A, et al. Prevalence, clinical correlates, and treatment of hypertension in elderly nursing home residents. SAGE (Systematic Assessment of Geriatric Drug Use via Epidemiology) Study Group. Arch Intern Med 1998;158:2377-85.

    Google Scholar 

  25. Kohno M, Yokokawa K, Yasunari K, Kano H, Minami M, Hanehira T, et al. Changes in plasma cardiac natriuretic peptides concentrations during 1 year treatment with angiotensin-converting enzyme inhibitor in elderly hypertensive patients with left ventricular hypertrophy. Int J Clin Pharmacol Ther 1997;35:38-42.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. www.bsl.nl/shop/

    M. Barents

Authors
  1. M. Barents
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. I. C. C. van der Horst
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. A. Voors
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J. L. Hillege
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. F. A. J. Muskiet
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M. J. L. de Jongste
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Barents.

Additional information

Zonnehuis Nursing Home, Zuidhorn, the Netherlands

Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands

Pathology and Laboratory Medicine, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands

Correspondence to: M. Barents Het Zonnehuis Nursing Home, suite 138, Hoofdstraat 2a, 9801 BW Zuidhorn, the Netherlands

Rights and permissions

Reprints and permissions

About this article

Cite this article

Barents, M., van der Horst, I.C.C., Voors, A.A. et al. Prevalence and misdiagnosis of chronic heart failure in nursing home residents: the role of B-type natriuretic peptides. NHJL 16, 123–128 (2008). https://doi.org/10.1007/BF03086130

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03086130

Search

Navigation